Article Abstract

The role of palbociclib in thyroid carcinoma with BRAF mutation

Authors: Nikolaos Tsoukalas, Konstantinos Tsapakidis, Krystallenia I. Alexandraki


Recurrent iodine-refractory differentiated thyroid cancer (RIR-DTC) is the centre of recent investigation on endocrine oncology. The treatment of most patients with differentiated thyroid cancer (DTC) includes surgery, thyroid hormone therapy, and selective use of radioactive iodine.

Article Options

Download Citation